ConductScience.org, home

Paper356569

Spironolactone.

Ochs HR and 3 others. Am Heart J, 1978. Cited by 73 papers, by iCite.

Cite this record

ConductScience Library. Spironolactone. Papers, record 356569. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/356569

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Spironolactone.
PubMed
Journal
Am Heart J
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
73
iCite
Relative citation ratio, by iCite
2.55
iCite
Revised in PubMed
2019-06-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ochs HRH R
2Greenblatt DJD J
3Bodem GG
4Smith TWT W

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SpironolactoneMajor topic
Androgen Antagonists
Animals
Blood Pressure
Chemical Phenomena
Chemistry
Drug Antagonism
Enzyme Induction
Enzyme Repression
Humans
Microsomes, Liver
Myocardial Contraction
Respiration
Salicylates
Water-Electrolyte Balance

Source PubMed

Download CSV of topics

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMIDTitleJournalYearIn PapersSource
39925732
A perspective on small molecules targeting the renin-angiotensin-aldosterone system and their utility in cardiovascular diseases: exploring the structural insights for rational drug discovery and development.
RSC Med Chem2025https://conductscience.org/library/papers/39925732PubMed
38068758An Update on Drug-Nutrient Interactions and Dental Decay in Older Adults.Nutrients2023https://conductscience.org/library/papers/38068758PubMed
37847437The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances.Clin Exp Nephrol2024https://conductscience.org/library/papers/37847437PubMed
33067334Guidelines on the management of ascites in cirrhosis.Gut2021https://conductscience.org/library/papers/33067334PubMed
29226122Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity?Front Med (Lausanne)2017https://conductscience.org/library/papers/29226122PubMed
23403436Effects of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with left ventricular systolic dysfunction: a meta-analysis of randomized controlled trials.Circ Heart Fail2013https://conductscience.org/library/papers/23403436PubMed
23105506Effect of spironolactone on acid and alkaline phosphatase in the testes of albino rat.Indian J Clin Biochem2005https://conductscience.org/library/papers/23105506PubMed
22081497Spironolactone and colitis: increased mortality in rodents and in humans.Inflamm Bowel Dis2012https://conductscience.org/library/papers/22081497PubMed
9009126Effect of fludrocortisone and spironolactone on sodium and potassium losses in secretory diarrhea.Dig Dis Sci1997https://conductscience.org/library/papers/9009126PubMed
7795556Corticosteroid receptor antagonists: a current perspective.Pharm World Sci1995https://conductscience.org/library/papers/7795556PubMed
7333059Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.Clin Pharmacokinet1981https://conductscience.org/library/papers/7333059PubMed
7332740Quantitative comparison of aldosterone antagonists in normal human subjects: prediction of therapeutic potency.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7332740PubMed
7295494Comparison of single and divided daily dose spironolactone in the control of hypertension.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7295494PubMed
7066166Spironolactone dose-response relationships in healthy subjects.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7066166PubMed
7056270Systolic time intervals during spironolactone treatment of digitalized and non-digitalized patients with ischaemic heart disease.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7056270PubMed
7035184Effect of spironolactone on systemic blood pressure, limb blood flow and response to sympathetic stimulation in hypertensive patients.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7035184PubMed
7032875Resistance to diuretics: emphasis on a pharmacological perspective.Drugs1981https://conductscience.org/library/papers/7032875PubMed
6849751The interaction of canrenone with oestrogen and progesterone receptors in human uterine cytosol.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6849751PubMed
6460516Relative potency and structure activity relationships of aldosterone antagonists in healthy man: correlation with animal experience.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6460516PubMed
6406259Effect of spironolactone on p-nitrophenol glucuronidation in isolated rat hepatocytes.Experientia1983https://conductscience.org/library/papers/6406259PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/356569

GET https://conductscience.org/api/papers/v1/356569/cited_by?page=2